ISRCTN11565460
Completed
Phase 2
Interreg diabetes centre for personalised medicine - unscheduled care in diabetes - study 2: inpatient study
niversity of the Highlands and Islands0 sites60 target enrollmentNovember 10, 2021
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of the Highlands and Islands
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
2021 Results article in https://doi.org/10.1111/dme.14753 (added 10/05/2022)
Investigators
Eligibility Criteria
Inclusion Criteria
- •Phase 2, Part B: pilot study – use of Flash Glucose Monitoring:
- •1\. Adults (aged 18 years and older)
- •2\. Diagnosed with diabetes
- •3\. Admitted to hospital wards defined in phase 1
- •4\. Able to read and understand the participant information sheet (PIS)
- •5\. Able to give written informed consent
- •Phase 2, Part C: pilot study \- evaluation interviews:
- •1\. Patients or HCPs that have participated in phase 2, part B
- •2\. Able to read and understand the participant information sheet (PIS)
- •3\. Able to give written informed consent
Exclusion Criteria
- •Phase 2, Part B: pilot study \- use of flash glucose monitoring:
- •1\. Children or young people (aged younger than 18 years)
- •2\. Not diagnosed with diabetes
- •3\. Admitted to hospital wards not defined in phase 1
- •4\. Pregnancy or gestational diabetes
- •5\. Significant intercurrent illness and/or terminal diagnosis
- •6\. Have a condition and/or treatment known to affect variability of blood glucose, such as on kidney dialysis
- •7\. Already using a Flash Glucose Monitoring or continuous monitoring device
- •8\. Unable to read and understand the participant information sheet (PIS)
- •9\. Unable to give written informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.Diabetes Mellitus, Type 2NCT02268929Hoffmann-La Roche414
Completed
Not Applicable
A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.Type II Diabetes MellitusNCT02156349Hoffmann-La Roche558
Completed
Not Applicable
Complex interventions to implement a diabetic retinopathy care pathway in the public health system in Kerala: a hybrid effectiveness-implementation study (Nayanaadram project)Diabetic retinopathyEye DiseasesISRCTN28942696Directorate of Health Services5,339
Completed
Not Applicable
Evaluation of a Diabetes-specific Cognitive Behavioural Treatment for Subthreshold DepressionDepressive SymptomsDiabetes MellitusNCT01009138Forschungsinstitut der Diabetes Akademie Mergentheim214
Recruiting
Not Applicable
Diabetes Mellitus Management using AyurvedaCTRI/2023/07/054665Sri Sarada Ayurveda Hospital